Fentanyl
Product Images NDC 68258-3023

18 FDA label images from Dispensing Solutions Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Fentanyl (NDC 68258-3023). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Fentanyl (4cda9cab F9ae 490c B85f 1f757981ac5a 01)

Structural Formula For Fentanyl (4cda9cab F9ae 490c B85f 1f757981ac5a 01)
Chemical structure of Fentanyl showing its molecular framework with rings and functional groups represented by chemical bonds and atom symbols.*
FDA Label Image

Graphic 1 (4cda9cab F9ae 490c B85f 1f757981ac5a 02)

Graphic 1 (4cda9cab F9ae 490c B85f 1f757981ac5a 02)
Illustration showing a labeled diagram of a fentanyl transdermal patch. The diagram identifies the impermeable backing, fentanyl in polyisobutene adhesive matrix, and the release liner components of the patch.*
FDA Label Image

Fentanyl Transdermal System Applied (4cda9cab F9ae 490c B85f 1f757981ac5a 03)

Fentanyl Transdermal System Applied (4cda9cab F9ae 490c B85f 1f757981ac5a 03)
A line graph depicting serum fentanyl concentration (ng/mL) over time (days), showing data before, during, and after application of the Fentanyl Transdermal System. The graph illustrates multiple applications and removals of the transdermal system, with concentration peaks and declines corresponding to the timing of applications and removals.*
FDA Label Image

Graphic 1 (4cda9cab F9ae 490c B85f 1f757981ac5a 04)

Graphic 1 (4cda9cab F9ae 490c B85f 1f757981ac5a 04)
An illustration showing the layers of a fentanyl patch, including the impermeable backing, the fentanyl in polyisobutene adhesive matrix, and the release liner. The image visually describes the components of the transdermal patch structure.*
FDA Label Image

Figure 1 (4cda9cab F9ae 490c B85f 1f757981ac5a 05)

Figure 1 (4cda9cab F9ae 490c B85f 1f757981ac5a 05)
An illustration showing placement of a transdermal patch labeled 'Figure 1' on the left upper chest area of a person's torso.*
FDA Label Image

Figure 2 (4cda9cab F9ae 490c B85f 1f757981ac5a 06)

Figure 2 (4cda9cab F9ae 490c B85f 1f757981ac5a 06)
An illustration depicting the upper torso of a person with a transdermal patch applied to the chest, indicating placement of a fentanyl transdermal system on the skin.*
FDA Label Image

Figure 3 (4cda9cab F9ae 490c B85f 1f757981ac5a 07)

Figure 3 (4cda9cab F9ae 490c B85f 1f757981ac5a 07)
An instructional diagram showing the application of a fentanyl patch on the chest area of a person. The illustration highlights the area where the patch should be placed, below the collarbone on the upper torso.*
FDA Label Image

Figure 4 (4cda9cab F9ae 490c B85f 1f757981ac5a 08)

Figure 4 (4cda9cab F9ae 490c B85f 1f757981ac5a 08)
An anatomical illustration showing the upper torso of a person with a patch applied to the shoulder area, likely representing the application site for a transdermal fentanyl product.*
FDA Label Image

Figure 5 (4cda9cab F9ae 490c B85f 1f757981ac5a 09)

Figure 5 (4cda9cab F9ae 490c B85f 1f757981ac5a 09)
An instructional illustration showing a person applying a Fentanyl transdermal patch to the upper chest area, just below the neck on the left side of the body.*
FDA Label Image

Figure 6 (4cda9cab F9ae 490c B85f 1f757981ac5a 10)

Figure 6 (4cda9cab F9ae 490c B85f 1f757981ac5a 10)
An instructional illustration labeled Figure 6 showing a pair of hands holding a small rectangular object, possibly demonstrating how to handle or use the product container or device related to Fentanyl by Dispensing Solutions Inc.*
FDA Label Image

Figure 7 (4cda9cab F9ae 490c B85f 1f757981ac5a 11)

Figure 7 (4cda9cab F9ae 490c B85f 1f757981ac5a 11)
An illustration labeled as Figure 7 showing two hands holding a rectangular object with a distinct dark central area. The image appears to demonstrate how to hold or handle the object, likely related to a pharmaceutical product.*
FDA Label Image

Figure 8 (4cda9cab F9ae 490c B85f 1f757981ac5a 12)

Figure 8 (4cda9cab F9ae 490c B85f 1f757981ac5a 12)
An instructional diagram labeled Figure 8 showing hands peeling back a black and white adhesive label or patch. The image likely demonstrates how to remove the backing from the product before application.*
FDA Label Image

Figure 9 (4cda9cab F9ae 490c B85f 1f757981ac5a 13)

Figure 9 (4cda9cab F9ae 490c B85f 1f757981ac5a 13)
An instructional illustration showing a person applying a patch to the upper chest area below the shoulder. The figure is labeled as Figure 9 and depicts proper placement of a transdermal patch on the skin.*
FDA Label Image

Figure 10 (4cda9cab F9ae 490c B85f 1f757981ac5a 14)

Figure 10 (4cda9cab F9ae 490c B85f 1f757981ac5a 14)
An instructional illustration showing two hands opening a foil blister pack by peeling or separating it, likely to access a medication within.*
FDA Label Image

Figure 11 (4cda9cab F9ae 490c B85f 1f757981ac5a 15)

Figure 11 (4cda9cab F9ae 490c B85f 1f757981ac5a 15)
An instructional diagram labeled Figure 11 depicting a hand holding and removing a circular component, likely a container lid or cap, from a larger circular base or device. The illustration suggests a step in a process involving opening or accessing the circular container.*
FDA Label Image

Image Of 25 Mcg/hr Carton (Ndc 68258 3023 1)

Image Of 25 Mcg/hr Carton (Ndc 68258 3023 1)
Fentanyl 25 mcg/hr transdermal systems label from Dispensing Solutions Inc. The label indicates a package of 5 transdermal patches with NDC 68258-3023-01. It includes dosage instructions, warnings about habit formation, and storage conditions. The label also features manufacturer and serialization details, as well as cautionary notes for external use and prescription only status.*
FDA Label Image

Image Of 75 Mcg/hr Carton (Ndc 68258 3024 1)

Image Of 75 Mcg/hr Carton (Ndc 68258 3024 1)
Label for Fentanyl 75 mcg/hr transdermal systems by Dispensing Solutions Inc. It contains 5 transdermal systems with each delivering fentanyl over 72 hours. The label includes warnings about external application, habit-forming potential, prescription-only status, lot number, expiration date, and storage instructions. Manufacturer Aveva Drug Delivery Systems and packaging details are also shown.*
FDA Label Image

Image Of 100 Mcg/hr Carton (Ndc 68258 3025 1)

Image Of 100 Mcg/hr Carton (Ndc 68258 3025 1)
The label is for Fentanyl 100 mcg/hr transdermal systems, containing 5 patches. The label includes the NDC 68258-3025-01 and product number 2F0305, manufactured by Aveva Drug Delivery Systems and packaged by Dispensing Solutions Inc. The label has warnings about external skin application, habit-forming potential, and storage instructions (store at 68°-77° F). It also indicates the product is Rx only, with multiple barcodes and a caution about federal law restrictions on transfer.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.